After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years, in an ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring ...

Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its Marietta location, creating 200 jobs ...

Global biopharma company GSK is investing up to $800 million in Pennsylvania and expanding its facility in Lancaster County.

The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker's settlement with ...

GSK meanwhile has previously suggest that the HBV therapy could collectively achieve sales of more than £2 billion ($2.45 billion) at peak, part of a new wave of therapies that it reckons could ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and Australian firm CSL Limited (OTC:CSLLY) to more than double the U.S. supply of ...